These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 526724)

  • 1. Monoamine oxidase inhibition by (+)-amphetamine in vivo [proceedings].
    Clarke DE; Miller HH; Shore PA
    Br J Pharmacol; 1979 Jul; 66(3):435P-436P. PubMed ID: 526724
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
    Miller HH; Clarke DE
    Commun Psychopharmacol; 1978; 2(4):319-25. PubMed ID: 729356
    [No Abstract]   [Full Text] [Related]  

  • 3. Rat heart monoamine oxidase: antagonism between d-amphetamine, oleic and arachidonic acids and monoamine oxidase inhibitors.
    Sen R; Parmar SS; Guha SR
    Proc West Pharmacol Soc; 1979; 22():109-13. PubMed ID: 515037
    [No Abstract]   [Full Text] [Related]  

  • 4. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
    Duarte JA; Carvalho F; Fernandes E; Remião F; Bastos ML; Magalhães J; Appell HJ
    Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo monoamine oxidase inhibition by d-amphetamine.
    Miller HH; Shore PA; Clarke DE
    Biochem Pharmacol; 1980 May; 29(10):1347-54. PubMed ID: 6901611
    [No Abstract]   [Full Text] [Related]  

  • 6. D-amphetamine and DL-alpha-N-methyltryptamine eliminate the irreversible inhibition of mitochondrial monoamine oxidase, caused by clorgyline. The specific action on the tyramine oxidation.
    Severina IS
    Biochem Int; 1984 Aug; 9(2):219-28. PubMed ID: 6487343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1978 May; 205(2):392-9. PubMed ID: 646869
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
    Green AL; el Hait MA
    J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings: Enhanced avoidance in poor performers as a model for evaluating antidepressant agents.
    Rech RH
    Psychopharmacol Bull; 1974 Oct; 10(4):18-9. PubMed ID: 4431860
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibition by d-amphetamine in ganglia and nerve endings.
    Filinger EJ; Stefano FJ
    Experientia; 1982 Jul; 38(7):844-5. PubMed ID: 7106259
    [No Abstract]   [Full Text] [Related]  

  • 11. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanisms by which amphetamine inhibits oxidative deamination of norepinephrine in brain.
    Rutledge CO
    J Pharmacol Exp Ther; 1970 Feb; 171(2):188-95. PubMed ID: 5413739
    [No Abstract]   [Full Text] [Related]  

  • 14. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of intraneuronal monoamine oxidase on the sympathomimetic response to amphetamine.
    Obianwu HO
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):69. PubMed ID: 5314439
    [No Abstract]   [Full Text] [Related]  

  • 16. Proceedings: Differential inhibition of mitochondrial monoamine oxidase from brain by hashish components.
    Schurr A; Livne A
    Isr J Med Sci; 1975 Nov; 11(11):1188. PubMed ID: 1205768
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modification of mitochondrial monoamine oxidase activity by certain amine inhibitors].
    Baumanis EA; Kalninia IE; Iriste AA; Gorkin VZ
    Vopr Med Khim; 1981; 27(1):72-7. PubMed ID: 6781140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Mechanism of antidepressant efficacy of monoamine oxidase inhibitors: inhibition of monoamine oxidase or of catecholamine reuptake.
    Snyder SH
    Psychopharmacol Bull; 1974 Oct; 10(4):16. PubMed ID: 4431859
    [No Abstract]   [Full Text] [Related]  

  • 19. Substrate selective inhibition of monoamine oxidase by mexiletine [proceedings].
    Callingham BA
    Br J Pharmacol; 1977 Sep; 61(1):118P-119P. PubMed ID: 912170
    [No Abstract]   [Full Text] [Related]  

  • 20. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.